Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.33M Buy
+50,000
New +$4.27M ﹤0.01% 4003
2026
Q1
– Sell
-50,000
Closed -$4.64M – 6745
2025
Q4
$4.64M Buy
+50,000
New +$5.45M ﹤0.01% 3818
2017
Q2
– Sell
-400
Closed -$24K – 6855
2017
Q1
$24K Sell
400
-200
-33% -$12.4K ﹤0.01% 6473
2016
Q4
$38K Buy
600
+200
+50% +$12.1K ﹤0.01% 6458
2016
Q3
$22K Buy
400
+300
+300% +$14.4K ﹤0.01% 6728
2016
Q2
$4K Buy
+100
New +$4.22K ﹤0.01% 6941
2015
Q3
– Sell
-400
Closed -$14K – 7390
2015
Q2
$14K Sell
400
-700
-64% -$25.4K ﹤0.01% 7124
2015
Q1
$40K Sell
1,100
-600
-35% -$22.4K ﹤0.01% 6758
2014
Q4
$72K Buy
1,700
+1,300
+325% +$51.9K ﹤0.01% 6698
2014
Q3
$16K Sell
400
-600
-60% -$24K ﹤0.01% 7009
2014
Q2
$41K Sell
1,000
-700
-41% -$26.6K ﹤0.01% 6792
2014
Q1
$60K Buy
+1,700
New +$64.4K ﹤0.01% 6525
2013
Q4
– Sell
-300
Closed -$13K – 6723
2013
Q3
$13K Sell
300
-400
-57% -$16.4K ﹤0.01% 6466
2013
Q2
$30K Buy
+700
New +$29.9K ﹤0.01% 6144

Other funds holding ITRI

Goldman Sachs's ITRI Position: Q2 2026 in Review

Goldman Sachs reduced its Itron (ITRI) stake by 20% in Q2 2026, selling an estimated $8.26M and leaving 390,028 shares worth $33.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

Goldman Sachs first reported a position in ITRI in Q2 2013 and has held it in 53 quarters since. The position peaked at $129M in Q2 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Goldman Sachs held 390,028 shares of Itron worth $33.7M as of Q2 2026.
  • Goldman Sachs sold 96,727 Itron shares in Q2 2026, an estimated $8.26M.
  • Itron made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2146 holding.
  • Goldman Sachs first reported a position in Itron in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Itron position peaked at $129M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.